Trinity Biotech PLC
TRIB- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000888721
No open-market purchases or sales by Trinity Biotech PLC insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $379.5K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Trinity Biotech PLC changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 34 | 29 | −5 |
| Shares | 5.40M | 5.66M | +260.5K (+4.8%) |
| Value | $20.3M | $16.6M | −$3.67M (−18.1%) |
New holders (3)
Institutions that held Trinity Biotech PLC at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 11,723 | $34.0K | 0.01% |
| Goldman Sachs Group Inc | 10,937 | $32.0K | 0.00% |
| Rockefeller Capital Management L.P. | 944 | $2.00K | 0.00% |
Sold out (8)
Institutions that held Trinity Biotech PLC at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Millennium Management LLC | 59,019 | $222.0K |
| Squarepoint Ops LLC | 36,450 | $137.0K |
| California Public Employees Retirement System | 28,100 | $106.0K |
| Mackenzie Financial Corp | 19,388 | $73.0K |
| Wolverine Trading, LLC | 10,010 | $40.0K |
| Simplex Trading, LLC | 7,518 | $28.0K |
| Group One Trading, L.P. | 272 | $1.00K |
| Private Capital Group, LLC | 54 | $0 |